E2F1 and hepatocellular carcinoma: Studies have shown that increased expression of E2F1 is associated with poor prognosis in HCC patients [41], and studies with a transgenic mouse model of E2F1-induced HCC showed that the network of transcription factors targeted by RBM8A is related to E2F1 [42].